Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Strategies to Achieve Further Cardiac and Renal Protection through Enhanced Renin-Angiotensin-Aldosterone System Inhibition
José Alfie, Lucas S. Aparicio, W. D.
Reviews on Recent Clinical Trials (2011) Vol. 6, Iss. 2, pp. 134-146
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Chronic Heart Failure and Inflammation
Sarah A. Dick, Slava Epelman
Circulation Research (2016) Vol. 119, Iss. 1, pp. 159-176
Open Access | Times Cited: 588
Natriuretic Peptide–Based Screening and Collaborative Care for Heart Failure
Mark Ledwidge, J. Gallagher, Carmel Conlon, et al.
JAMA (2013) Vol. 310, Iss. 1, pp. 66-66
Closed Access | Times Cited: 538
Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis
Gemma Currie, Alison Taylor, Toshiro Fujita, et al.
BMC Nephrology (2016) Vol. 17, Iss. 1
Open Access | Times Cited: 172
Renal and Cardiac Effects of DPP-4 Inhibitors – from Preclinical Development to Clinical Research
Berthold Hocher, Christoph Reichetzeder, Markus Alter
Kidney & Blood Pressure Research (2012) Vol. 36, Iss. 1, pp. 65-84
Closed Access | Times Cited: 136
The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis
Ziv Harel, Cameron Gilbert, Ron Wald, et al.
BMJ (2012) Vol. 344, Iss. jan09 1, pp. e42-e42
Open Access | Times Cited: 118
Alamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes
Itamar Couto Guedes de Jesus, Sérgio Scalzo, Fabiana Alves, et al.
AJP Cell Physiology (2018) Vol. 314, Iss. 6, pp. C702-C711
Open Access | Times Cited: 66
Mass spectrometry for the molecular imaging of angiotensin metabolism in kidney
Nadja Grobe, Khalid M. Elased, David R. Cool, et al.
AJP Endocrinology and Metabolism (2012) Vol. 302, Iss. 8, pp. E1016-E1024
Open Access | Times Cited: 62
Angiotensin 1–7: A peptide for preventing and treating metabolic syndrome
Sérgio Henrique Sousa Santos, João Marcus Oliveira Andrade
Peptides (2014) Vol. 59, pp. 34-41
Closed Access | Times Cited: 55
The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review
Luciana Mendes Araújo Borém, João Felício Rodrigues Neto, Igor Viana Brandi, et al.
Hypertension Research (2018) Vol. 41, Iss. 6, pp. 394-405
Open Access | Times Cited: 48
Long-Term Effects of Spironolactone on Kidney Function and Hyperkalemia-Associated Hospitalization in Patients with Chronic Kidney Disease
Chen‐Ta Yang, Chew‐Teng Kor, Yao‐Peng Hsieh
Journal of Clinical Medicine (2018) Vol. 7, Iss. 11, pp. 459-459
Open Access | Times Cited: 43
Anti-Inflammatory Effects of Ang-(1-7) in Ameliorating HFD-Induced Renal Injury through LDLr-SREBP2-SCAP Pathway
Yaning Zheng, Lin Tang, Wenhan Huang, et al.
PLoS ONE (2015) Vol. 10, Iss. 8, pp. e0136187-e0136187
Open Access | Times Cited: 29
Effects of Combined Endothelin A Receptor and Renin-Angiotensin System Blockade on the Course of End-Organ Damage in 5/6 Nephrectomized Ren-2 Hypertensive Rats
Ivana Vaněčková, Petr Kujal, Zuzana Husková, et al.
Kidney & Blood Pressure Research (2012) Vol. 35, Iss. 5, pp. 382-392
Closed Access | Times Cited: 31
Protective effect of 3-n-butylphthalide against hypertensive nephropathy in spontaneously hypertensive rats
Jun Zhu, Yantao Zhang, Chang-hai Yang
Molecular Medicine Reports (2014) Vol. 11, Iss. 2, pp. 1448-1454
Open Access | Times Cited: 28
Effects of a community-based weight loss intervention on adipose tissue circulating factors
Gary D. Miller, Scott Isom, Timothy M. Morgan, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2014) Vol. 8, Iss. 4, pp. 205-211
Open Access | Times Cited: 22
The Therapeutic Role of Renin-Angiotensin System Blockers in Obesity- Related Renal Disorders
Sérgio Henrique Sousa Santos, Ana Cristina Simões e Silva
Current Clinical Pharmacology (2014) Vol. 9, Iss. 1, pp. 2-9
Closed Access | Times Cited: 21
Validation of a therapeutic scheme for the treatment of resistant hypertension
J. Segura, César Cerezo, José A. García‐Donaire, et al.
Journal of the American Society of Hypertension (2011) Vol. 5, Iss. 6, pp. 498-504
Closed Access | Times Cited: 20
The effect of lycopene treatment on ACE activity in rats with experimental diabetes
Serif Ozmutlu, Semiha Dede, Ebubekir Ceylan
Journal of the Renin-Angiotensin-Aldosterone System (2012) Vol. 13, Iss. 3, pp. 328-333
Open Access | Times Cited: 19
The tolerability and safety profile of patiromer: a novel polymer-based potassium binder for the treatment of hyperkalemia
Bertram Pitt, Dahlia Garza
Expert Opinion on Drug Safety (2018) Vol. 17, Iss. 5, pp. 525-535
Closed Access | Times Cited: 17
Dl-3-n-Butylphthalide Ameliorates Diabetic Nephropathy by Ameliorating Excessive Fibrosis and Podocyte Apoptosis
Jingyu Xu, Zonghao Tang, Youwu He, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 10
Management of proteinuria in clinical practice after kidney transplantation
Juan Carlos Ruiz, Ana Sánchez‐Fructuoso, Sofía Zárraga
Transplantation Reviews (2011) Vol. 26, Iss. 1, pp. 36-43
Closed Access | Times Cited: 8
RU28318, an Aldosterone Antagonist, in Combination with an ACE Inhibitor and Angiotensin Receptor Blocker Attenuates Cardiac Dysfunction in Diabetes
Ibrahim F. Benter, Fawzi Babiker, Ibrahim Al‐Rashdan, et al.
Journal of Diabetes Research (2013) Vol. 2013, pp. 1-14
Open Access | Times Cited: 7
Cardiorenal Syndromes: Advances in Determining Diagnosis, Prognosis and Therapy
Peter A. McCullough, James A. Tumlin
Journal of Cardiovascular Diseases & Diagnosis (2015) Vol. 03, Iss. 05
Open Access | Times Cited: 6
Medium-term follow-up of renal function in hypoxaemic congenital heart disease patients
Efrén Martínez‐Quintana, Fayna Rodríguez‐González
Cardiology in the Young (2015) Vol. 26, Iss. 6, pp. 1137-1143
Closed Access | Times Cited: 6
Renal-protective effect of nicousamide on hypertensive nephropathy in spontaneously hypertensive rats
Sen Zhang, Yan Li, Hongyan Li, et al.
Biomedical Reports (2012) Vol. 1, Iss. 1, pp. 34-40
Open Access | Times Cited: 6
Efficacy of Aliskiren in Japanese Chronic Kidney Disease Patients with Hypertension
Yukinao Sakai, Tomoyuki Otsuka, Dai Ohno, et al.
Renal Failure (2012) Vol. 34, Iss. 4, pp. 442-447
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top